196
Views
3
CrossRef citations to date
0
Altmetric
Case Report

Lymphoepithelioma‑Like Cholangiocarcinoma with Hepatitis C Virus Infection Treated by Microwave Ablation: A Literature Review and Case Report

, , , , &
Pages 2155-2160 | Published online: 04 Jul 2022

References

  • Labgaa I, Stueck A, Ward SC. Lymphoepithelioma-Like Carcinoma in Liver. Am J Pathol. 2017;187(7):1438–1444. doi:10.1016/j.ajpath.2017.02.022
  • Applebaum EL, Mantravadi P, Haas R. Lymphoepithelioma of the nasopharynx. Laryngoscope. 1982;92(5):510–514. doi:10.1288/00005537-198205000-00009
  • Bosman FT, Carneiro F, Hruban RH. WHO Classification of Tumours of the Digestive System. 4th ed. World Health Organization; 2010:417.
  • Lin A, Alpert L, Hart J, Chapman C, Pillai AA. Lymphoepithelioma-Like Carcinomas: a Rare Variant of Cholangiocarcinoma. Hepatology. 2020;72(1):353–355. doi:10.1002/hep.31102
  • Vortmeyer AO, Kingma DW, Fenton RG, et al. Hepatobiliary lymphoepithelioma-like carcinoma associated with Epstein-Barr virus. Am J Clin Pathol. 1998;109(1):90–95. doi:10.1093/ajcp/109.1.90
  • Ortiz MR, Garijo G, Adrados M, et al. Epstein-Barr Virus-Associated Cholangiocarcinoma with Lymphoepithelioma-Like Component. Int J Surg Pathol. 2000;8(4):347–351. doi:10.1177/106689690000800418
  • Zhang K, Tao C, Tao Z, et al. Lymphoepithelioma-like carcinoma in liver not associated with Epstein-Barr virus: a report of 3 cases and literature review. Diagn Pathol. 2020;15(1):115. doi:10.1186/s13000-020-01035-6
  • Ding Y, Sun Z, You W, et al. Lymphoepithelioma-like intrahepatic cholangiocarcinoma with Epstein-Barr virus infection: report of a rare case. Ann Transl Med. 2019;7(18):497. doi:10.21037/atm.2019.08.105
  • Adachi S, Morimoto O, Kobayashi T. Lymphoepithelioma-like cholangiocarcinoma not associated with EBV. Pathol Int. 2008;58(1):69–74. doi:10.1111/j.1440-1827.2007.02192.x
  • Nogami A, Saito S, Hasegawa H, et al. Lymphoepithelioma-like cholangiocarcinoma with Epstein-Barr virus infection treated by radiofrequency ablation. Clin J Gastroenterol. 2021;14(2):638–644. doi:10.1007/s12328-020-01303-4
  • Izzo F, Granata V, Grassi R, et al. Radiofrequency Ablation and Microwave Ablation in Liver Tumors: an Update. Oncologist. 2019;24(10):e990–e1005. doi:10.1634/theoncologist.2018-0337
  • European Association For The Study Of The Liver. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. Eur J Cancer. 2012;48(5):599–641. doi:10.1016/j.ejca.2011.12.021
  • Knavel EM, Brace CL. Tumor ablation: common modalities and general practices. Tech Vasc Interv Radiol. 2013;16(4):192–200. doi:10.1053/j.tvir.2013.08.002
  • Glassberg MB, Ghosh S, Clymer JW, et al. Microwave ablation compared with radiofrequency ablation for treatment of hepatocellular carcinoma and liver metastases: a systematic review and meta-analysis. Onco Targets Ther. 2019;12:6407–6438. doi:10.2147/ott.S204340
  • Maurea S, Caleo O, Mollica C, et al. Comparative diagnostic evaluation with MR cholangiopancreatography, ultrasonography and CT in patients with pancreatobiliary disease. Radiol Med. 2009;114(3):390–402. doi:10.1007/s11547-009-0374-x
  • Yang Q, Cai Q, Wen H, et al. The CT and MRI Features of Primary Intrahepatic Lymphoepithelioma-Like Cholangiocarcinoma. AJR Am J Roentgenol. 2021;216(2):393–402. doi:10.2214/ajr.20.22937
  • D’Antuono F, De Luca S, Mainenti PP, et al. Comparison Between Multidetector CT and High-Field 3T MR Imaging in Diagnostic and Tumour Extension Evaluation of Patients with Cholangiocarcinoma. J Gastrointest Cancer. 2020;51(2):534–544. doi:10.1007/s12029-019-00276-z
  • Maurea S, Corvino A, Imbriaco M, et al. Simultaneous non-functioning neuroendocrine carcinoma of the pancreas and extra-hepatic cholangiocarcinoma. A case of early diagnosis and favorable post-surgical outcome. J Pancreas. 2011;12(3):255–258.
  • Rizzo A, Brandi G. Pitfalls, challenges, and updates in adjuvant systemic treatment for resected biliary tract cancer. Expert Rev Gastroenterol Hepatol. 2021;15(5):547–554. doi:10.1080/17474124.2021.1890031
  • Rizzo A, Ricci AD, Brandi G. Pemigatinib: hot topics behind the first approval of a targeted therapy in cholangiocarcinoma. Cancer Treat Res Commun. 2021;27:100337. doi:10.1016/j.ctarc.2021.100337